同期经尿道手术治疗浅表性膀胱癌合并良性前列腺增生疗效分析

Treatment of superficial bladder cancer with benign prostatic hyperplasia by transurethral surgery

目的:探讨同期经尿道手术治疗浅表性膀胱癌合并良性前列腺增生的疗效。方法:收集浅表性膀胱癌患者80例,随机分为两组。对照组患者给予膀胱肿瘤部分切除术,试验组患者则给予经尿道膀胱肿瘤超脉冲等离子双极电切术。比较两组患者术中总出血量、手术时间、治疗前后国际前列腺症状评分、最大尿流率,以及两组患者24个月内复发情况。结果:试验组较对照组患者比较,治疗前国际前列腺症状评分、最大尿流率差异不明显,不具有统计学意义(P>0.05);治疗前与治疗后比较,两组患者国际前列腺症状评分、最大尿流率比较均显著改善,差异具有统计学意义(P<0.01)。试验组与对照组患者比较,术中总出血量、手术时间均显著减少,差异具有统计学意义(P<0.01)。试验组与对照组患者治疗后非手术区域复发、前列腺窝内复发情况比较,差异不具有统计学意义(P>0.05)。结论:同期经尿道手术治疗浅表性膀胱癌合并良性前列腺增生效果显著,相较于膀胱肿瘤部分切除术而言经尿道膀胱肿瘤超脉冲等离子双极电切术术中出血更少,手术持续时间更短。但值得注意的是手术质量的好坏与前列腺窝内复发有着一定关系,术者应严格避免医源性种植转移。

Objective:To investigate the efficacy of simultaneous transurethral surgery in the treatment of superficial bladder cancer with benign prostatic hyperplasia.Methods:Eighty patients with superficial bladder cancer who were enrolled from January 2013 to March 2015 were randomly divided into two groups.The patients in the control group received partial resection of the bladder tumor.The patients in the experimental group were treated with transurethral bladder tumor super pulse plasma The total intraoperative blood loss and operation time were compared between the two groups before and after treatment.The international prostate symptom score,the maximum urinary flow rate and the two groups were 24 months Internal recurrence.Results:Compared with the control group,there was no significant difference between the experimental group and the control group before and after treatment(P>0.05).Before treatment and treatment,the difference was not significant(P>0.05)After comparison,the international prostate symptom score and the maximum urinary flow rate of the two groups were significantly improved,the difference was significant,with significant statistical significance(P<0.01).Compared with the control group,the total blood loss and operation time were significantly decreased in the experimental group and the control group(P<0.01).After the chi-square test,there was no significant difference between the experimental group and the control group in the recurrence of the non-surgical area and the recurrence of the prostate fossa(P>0.05).But it is worth noting that the experimental group has a case of recurrence of the prostate fossa,can not rule out the cause of iatrogenic(surgical)due to,it needs to pay attention to strict quality control surgery.Conclusion:The same period of transurethral resection of superficial bladder cancer with benign prostatic hyperplasia is extremely safe and effective,compared with partial resection of bladder tumor in terms of transurethral bladder tumor ultra pulse plasma bipolar resection less bleeding,Surgery duration is shorter,worthy of clinical promotion,with reference.But it is worth noting that the quality of surgery is good or bad with the recurrence of the prostate fossa has a certain relationship,the surgeon should strictly avoid iatrogenic planting transfer.